These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22999854)

  • 1. [Factsheets: support in the analysis of recipients' adverse reactions].
    Bazin A; Trophilme C; Py JY; Caldani C; Daurat G; Hauser L; Leconte des Floris MF; Moncharmont P; Pillonel J; Renaudier P; Richomme X; Sailliol A; Boudjedir K; Ounnoughene N; Sandid I; Vo-Mai MP; Carlier M
    Transfus Clin Biol; 2012 Nov; 19(4-5):187-94. PubMed ID: 22999854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recipients adverse reactions: guidance supports].
    Bazin A
    Transfus Clin Biol; 2010 Dec; 17(5-6):366-74. PubMed ID: 21051267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Transfusion transmitted bacterial infectious (TTBI) with blood component accountability score 2: Retrospective analysis of the French e-fit database 2000-2007. Groupe de travail–validation des IBTT (Working group for validation of transfusion-transmitted bacterial infections)].
    Delbosc A; Lafeuillade B; Petermann R; Eb F; Ounnoughene N
    Transfus Clin Biol; 2011 Feb; 18(1):26-35. PubMed ID: 21310643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [What to do in case of adverse event in recipient at the French National Blood Service?].
    Leconte des Floris MF; Pourcelot L; Hauser L; Hervé I; Waller C; Bardiaux L; Morel P
    Transfus Clin Biol; 2012 Nov; 19(4-5):182-6. PubMed ID: 23006955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Reporting and notification of transfusion serious adverse events in France].
    Daurat G
    Transfus Clin Biol; 2010 Dec; 17(5-6):362-5. PubMed ID: 21050790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hospital haemovigilance and adverse events or reactions: who notifies and what?].
    Gouëzec H; Bazin A; Lassale B; Huchet C; Artéro N
    Transfus Clin Biol; 2012 Nov; 19(4-5):178-81. PubMed ID: 23043856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemovigilance: an effective tool for improving transfusion practice.
    de Vries RR; Faber JC; Strengers PF;
    Vox Sang; 2011 Jan; 100(1):60-7. PubMed ID: 21175656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International haemovigilance: what have we learned and what do we need to do next?
    Wood EM; Ang AL; Bisht A; Bolton-Maggs PH; Bokhorst AG; Flesland O; Land K; Wiersum-Osselton JC; Schipperus MR; Tiberghien P; Whitaker BI
    Transfus Med; 2019 Aug; 29(4):221-230. PubMed ID: 30729612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Réactions transfusionnelles].
    Chiaroni J
    Rev Prat; 2018 Nov; 68(9):1029-1033. PubMed ID: 30869366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eight years with haemovigilance in Norway. What have we learnt?
    Steinsvåg CT; Espinosa A; Flesland Ø
    Transfus Apher Sci; 2013 Dec; 49(3):548-52. PubMed ID: 24157220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Seventeen years of haemovigilance in France: assessment and outlook].
    Carlier M; Vo Mai MP; Fauveau L; Ounnoughene N; Sandid I; Renaudier P
    Transfus Clin Biol; 2011 Apr; 18(2):140-50. PubMed ID: 21474356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [What is the use of hemovigilance?].
    Quaranta JF; Canivet N
    Transfus Clin Biol; 1998 Dec; 5(6):415-21. PubMed ID: 9894333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Review of the main haemovigilance systems in the world].
    Faber JC
    Transfus Clin Biol; 2009 May; 16(2):86-92. PubMed ID: 19442556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First annual report of Chinese haemovigilance network.
    Yin Y; Tian X; Li L; Kong Y; Wang J; Lin F; Song N; Chen Q; Gan J; Peng T; Li X; Wu Y; Ge H; Wang H; Jiang J; Bai L; Ji H; Zhao G; Huang Y; Liu Z;
    Vox Sang; 2021 Jul; 116(6):718-724. PubMed ID: 33423307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Online reporting system for transfusion-related adverse events to enhance recipient haemovigilance in Japan: a pilot study.
    Odaka C; Kato H; Otsubo H; Takamoto S; Okada Y; Taneichi M; Okuma K; Sagawa K; Hoshi Y; Tasaki T; Fujii Y; Yonemura Y; Iwao N; Tanaka A; Okazaki H; Momose SY; Kitazawa J; Mori H; Matsushita A; Nomura H; Yasoshima H; Ohkusa Y; Yamaguchi K; Hamaguchi I
    Transfus Apher Sci; 2013 Feb; 48(1):95-102. PubMed ID: 22954634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The French Haemovigilance System: organization and results for 2003.
    Rebibo D; Hauser L; Slimani A; Hervé P; Andreu G
    Transfus Apher Sci; 2004 Oct; 31(2):145-53. PubMed ID: 15501418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recipients adverse reactions in the Ibn Sina Hospital of Rabat: State 1999-2013].
    Ouadghiri S; Brick C; Benseffaj N; Atouf O; Essakalli M
    Transfus Clin Biol; 2017 Feb; 24(1):23-27. PubMed ID: 27843110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfusion-associated hazards: A revisit of their presentation.
    Garraud O; Sut C; Haddad A; Tariket S; Aloui C; Laradi S; Hamzeh-Cognasse H; Bourlet T; Zeni F; Aubron C; Ozier Y; Laperche S; Peyrard T; Buffet P; Guyotat D; Tavernier E; Cognasse F; Pozzetto B; Andreu G
    Transfus Clin Biol; 2018 May; 25(2):118-135. PubMed ID: 29625790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Delayed adverse reactions to blood donation: From haemovigilance data to specific studies].
    Py JY; Durieux S; Barnoux M; Sapey T
    Transfus Clin Biol; 2016 Nov; 23(4):233-239. PubMed ID: 27769684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Post-transfusion pulmonary oedema: the French hemovigilance network classification method].
    Ozier Y; Renaudier P; Caldani C; Aguilon P; Canivet N; Fabrigli P; Mertes PM; Muller JY; Rebibo D; Tazerout M; Trophilme C; Willaert B; Carlier M
    Transfus Clin Biol; 2010 Dec; 17(5-6):284-90. PubMed ID: 21051260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.